A top-tier pharmaceutical company specializing in drug development, clinical trials, and commercial distribution across global markets. The client operates digital platforms for clinical data management, physician portals, and patient assistance programs. Their infrastructure spans regulated cloud environments, APIs for CRO integrations, and internal R&D platforms.
As the client accelerated digital transformation in R&D and commercial operations, they faced increasing cybersecurity challenges across web portals, APIs, and AWS-hosted infrastructure:
- Inconsistent access controls in clinical trial submission portals and HCP login interfaces created risks of unauthorized data access
- APIs used for lab results ingestion and CRO partner data exchange lacked proper authentication enforcement and rate-limiting
- AWS configurations revealed exposed S3 buckets, over-permissioned IAM roles, and misconfigured network security groups
- Limited offensive testing exposed the business to HIPAA and GxP compliance gaps
Evoke implemented a combined Offensive Security and Application Security framework to address risks across pharma operations and regulatory systems:
- Performed web and API penetration testing
- Conducted AWS Cloud Security Assessments
- Delivered a Security Console Dashboard
- Identified and remediated 25+ critical vulnerabilities across high-risk pharma data systems
- Reduced time-to-remediation by 55% through sprint-based integration of security into dev workflows
- Prevented unauthorized data access in clinical and post-market platforms
- Strengthened compliance alignment with HIPAA, FDA audit requirements, and GDPR (for EU operations)
- Improved visibility across business, QA, and InfoSec teams using real-time risk dashboards